CNO Financial Group (CNO)
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
$56.75+0.05%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
Broken: Primary pillar broken — Operating EPS between $4.25 and $4.45 for fiscal year 2026: FY26 EPS guidance $1.71 vs target $4.25-$4.45.
CNO Financial Group targets operating EPS between $4.25 and $4.45 for 2026. The company has shown a recent EPS beat with 12.9% surprise and 2.5% revenue growth year-over-year. Profit margins remain robust, supporting steady earnings. The stable management and low risk profile add confidence.
Revenue is expected to decline about 5% next year, which could pressure earnings. The stock trades about 9% above our valuation estimate, suggesting limited upside. Any sustained miss on EPS or margin compression would weaken the thesis.
The market prices in about -5% revenue growth and expects EPS near $4.48 for 2026. Our view is slightly more optimistic on earnings growth and margin stability, expecting EPS up to $4.45 with steady profit margins.
Breaks if: Significant management turnover or execution failures reported
Breaks if: Operating EPS falls below $4.25 or above $4.45 in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
CNO represents a stable investment with a focus on sustaining and growing operating earnings. The current thesis state is weakened due to recent financial performance dropping within its industry, despite management's commitment to growth.
The market currently prices CNO at a premium compared to its peers, indicating that investors expect strong performance. However, the expectations gap suggests that there may be some room for disappointment if results do not meet these high expectations.
Management has shown a commitment to growing operating earnings and maintaining disciplined capital management. However, recent changes in company quality and management scores indicate potential challenges ahead, even with a low probability of missing earnings.
The thesis hinges on the performance of sector bellwethers like MET, AFL, and PRU. If these companies continue to perform well, it could support CNO's growth. Conversely, any negative shifts in their performance could impact CNO's momentum.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the outlook for operating EPS. The raised guidance targets operating EPS of $4.25 to $4.45 for 2026. Growth in worksite and Medicare insurance markets also reinforces this positive view.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
CNO targets an operating EPS range of $4.25 to $4.45 for the fiscal year 2026.
Breaks if: Profit margins fall significantly below 25% in FY26
Breaks if: Revenue decline worse than -5% YoY over next 12 months
Overall, the next 1 to 3 years will depend on CNO's ability to maintain its growth trajectory amid sector challenges. Not investment advice.